A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 27 abr. 2026. , 2018
APA
Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
NLM
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Vancouver
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIROTSU, Camila e DRAGER, Luciano Ferreira. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study. European respiratory journal, v. 52, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1183/13993003.01150-2018. Acesso em: 27 abr. 2026.
APA
Hirotsu, C., & Drager, L. F. (2018). Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study. European respiratory journal, 52( 5). doi:10.1183/13993003.01150-2018
NLM
Hirotsu C, Drager LF. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study [Internet]. European respiratory journal. 2018 ; 52( 5):[citado 2026 abr. 27 ] Available from: https://doi.org/10.1183/13993003.01150-2018
Vancouver
Hirotsu C, Drager LF. Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study [Internet]. European respiratory journal. 2018 ; 52( 5):[citado 2026 abr. 27 ] Available from: https://doi.org/10.1183/13993003.01150-2018
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTALDELLI-MAIA, Joao Mauricio et al. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes. Psychiatry research, v. 266, p. 275-283, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.psychres.2018.03.018. Acesso em: 27 abr. 2026.
APA
Castaldelli-maia, J. M., Andrade, L. H., Storr, C. L., Viana, M. C., Andrade, A. G. de, & Martins, S. S. (2018). The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes. Psychiatry research, 266, 275-283. doi:10.1016/j.psychres.2018.03.018
NLM
Castaldelli-maia JM, Andrade LH, Storr CL, Viana MC, Andrade AG de, Martins SS. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes [Internet]. Psychiatry research. 2018 ; 266 275-283.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.psychres.2018.03.018
Vancouver
Castaldelli-maia JM, Andrade LH, Storr CL, Viana MC, Andrade AG de, Martins SS. The latent trait of ICD-11 nicotine dependence criteria: dimensional and categorical phenotypes [Internet]. Psychiatry research. 2018 ; 266 275-283.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.psychres.2018.03.018
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDIEL, Mario H. e BONFA, Eloisa Silva Dutra de Oliveira e SILVA, Clovis Artur Almeida da. Therapeutic guidelines for Latin American Lupus patients methodology. Jcr-journal of clinical rheumatology, v. 24, n. 1, p. 41-44, 2018Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000000662. Acesso em: 27 abr. 2026.
APA
Cardiel, M. H., Bonfa, E. S. D. de O., & Silva, C. A. A. da. (2018). Therapeutic guidelines for Latin American Lupus patients methodology. Jcr-journal of clinical rheumatology, 24( 1), 41-44. doi:10.1097/RHU.0000000000000662
NLM
Cardiel MH, Bonfa ESD de O, Silva CAA da. Therapeutic guidelines for Latin American Lupus patients methodology [Internet]. Jcr-journal of clinical rheumatology. 2018 ; 24( 1): 41-44.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1097/RHU.0000000000000662
Vancouver
Cardiel MH, Bonfa ESD de O, Silva CAA da. Therapeutic guidelines for Latin American Lupus patients methodology [Internet]. Jcr-journal of clinical rheumatology. 2018 ; 24( 1): 41-44.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1097/RHU.0000000000000662
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 27 abr. 2026.
APA
Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
NLM
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
Vancouver
Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCINTYRE, William F. e HAJJAR, Ludhmila. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis. Jama-journal of the american medical association, v. 319, n. 18, p. 1889-1900, 2018Tradução . . Disponível em: https://doi.org/10.1001/jama.2018.4528. Acesso em: 27 abr. 2026.
APA
Mcintyre, W. F., & Hajjar, L. (2018). Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis. Jama-journal of the american medical association, 319( 18), 1889-1900. doi:10.1001/jama.2018.4528
NLM
Mcintyre WF, Hajjar L. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis [Internet]. Jama-journal of the american medical association. 2018 ; 319( 18): 1889-1900.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1001/jama.2018.4528
Vancouver
Mcintyre WF, Hajjar L. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock A Systematic Review and Meta-analysis [Internet]. Jama-journal of the american medical association. 2018 ; 319( 18): 1889-1900.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1001/jama.2018.4528
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARYTAN, David M. e BURDMANN, Emmanuel de Almeida. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, v. 70, n. 4, p. 522-531, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/21785. Acesso em: 27 abr. 2026.
APA
Charytan, D. M., & Burdmann, E. de A. (2017). ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, 70( 4), 522-531. doi:10.1053/j.ajkd.2017.04.018
NLM
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 abr. 27 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Vancouver
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2026 abr. 27 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIAVEGATTO FILHO, Alexandre Dias Porto et al. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys. BMJ Open, v. 7, n. 10, p. art. e01767 [12], 2017Tradução . . Disponível em: https://doi.org/10.1136/bmjopen-2017-017679. Acesso em: 27 abr. 2026.
APA
Chiavegatto Filho, A. D. P., Sampson, L., Martins, S. S., Yu, S., Huang, Y., He, Y., et al. (2017). Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys. BMJ Open, 7( 10), art. e01767 [12]. doi:10.1136/bmjopen-2017-017679
NLM
Chiavegatto Filho ADP, Sampson L, Martins SS, Yu S, Huang Y, He Y, Lee S, Hu C, Zaslavsky A, Kessler RC, Galea S. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys [Internet]. BMJ Open. 2017 ;7( 10): art. e01767 [12].[citado 2026 abr. 27 ] Available from: https://doi.org/10.1136/bmjopen-2017-017679
Vancouver
Chiavegatto Filho ADP, Sampson L, Martins SS, Yu S, Huang Y, He Y, Lee S, Hu C, Zaslavsky A, Kessler RC, Galea S. Neighbourhood characteristics and mental disorders in three Chinese cities: multilevel models from the World Mental Health Surveys [Internet]. BMJ Open. 2017 ;7( 10): art. e01767 [12].[citado 2026 abr. 27 ] Available from: https://doi.org/10.1136/bmjopen-2017-017679
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KREUTER, Michael e KAIRALLA, Ronaldo Adib. Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, v. 5, n. 12, p. 968-980, 2017Tradução . . Disponível em: https://doi.org/10.1016/S2213-2600(17)30383-1. Acesso em: 27 abr. 2026.
APA
Kreuter, M., & Kairalla, R. A. (2017). Palliative care in interstitial lung disease: living well. Lancet respiratory medicine, 5( 12), 968-980. doi:10.1016/S2213-2600(17)30383-1
NLM
Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1
Vancouver
Kreuter M, Kairalla RA. Palliative care in interstitial lung disease: living well [Internet]. Lancet respiratory medicine. 2017 ; 5( 12): 968-980.[citado 2026 abr. 27 ] Available from: https://doi.org/10.1016/S2213-2600(17)30383-1